Notice
26 Sep 2025
zika virus, patent licensing, cancer treatment, oncolytic therapy, advocate aurora, biotechnology, nih
đź’ŠExclusive License for Zika Virus Therapy by NIH and Advocate Aurora
The National Institute of Allergy and Infectious Diseases, an institute of the National Institutes of Health, Department of Health and Human Services, Department of Health and Human Services, is contemplating the grant of an exclusive patent license to Advocate Aurora Research Institute, located in Milwaukee, Wisconsin, to practice the inventions embodied in the patent applications listed in the Supplementary Information section of this notice.
Learn More